{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:38:12Z","timestamp":1789717092189,"version":"4.0.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T00:00:00Z","timestamp":1391731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2051-5960-2-15","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T21:03:45Z","timestamp":1391720625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Lipid dysfunction and pathogenesis of multiple system atrophy"],"prefix":"10.1186","volume":"2","author":[{"given":"Jonathan M","family":"Bleasel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna H","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojin Scott","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,7]]},"reference":[{"issue":"2","key":"92_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870120203","volume":"12","author":"G Wenning","year":"1997","unstructured":"Wenning G, Tison F, Ben Shlomo Y, Daniel S, Quinn N: Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997, 12(2):133\u2013147. 10.1002\/mds.870120203","journal-title":"Mov Disord"},{"issue":"2","key":"92_CR2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s004010100367","volume":"102","author":"T Ozawa","year":"2001","unstructured":"Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, Tsuji S: Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol 2001, 102(2):188\u2013190.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"92_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/brain\/117.4.835","volume":"117","author":"G Wenning","year":"1994","unstructured":"Wenning G, Shlomo YB, Magalhaes M, Danie S, Quinn N: Clinical features and natural history of multiple system atrophy. Brain 1994, 117(4):835\u2013845. 10.1093\/brain\/117.4.835","journal-title":"Brain"},{"issue":"2","key":"92_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/mds.21839","volume":"23","author":"A Schrag","year":"2008","unstructured":"Schrag A, Wenning GK, Quinn N, Ben\u2012Shlomo Y: Survival in multiple system atrophy. Mov Disord 2008, 23(2):294\u2013296. 10.1002\/mds.21839","journal-title":"Mov Disord"},{"issue":"3","key":"92_CR5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jnnp.2006.103929","volume":"78","author":"S Papapetropoulos","year":"2007","unstructured":"Papapetropoulos S, Tuchman A, Laufer D, Papatsoris AG, Papapetropoulos N, Mash DC: Causes of death in multiple system atrophy. J Neurol Neurosurg Psychiatry 2007, 78(3):327\u2013329.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9192","key":"92_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","volume":"354","author":"A Schrag","year":"1999","unstructured":"Schrag A, Ben-Shlomo Y, Quinn N: Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999, 354(9192):1771\u20131775. 10.1016\/S0140-6736(99)04137-9","journal-title":"Lancet"},{"issue":"5","key":"92_CR7","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","volume":"49","author":"JH Bower","year":"1997","unstructured":"Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997, 49(5):1284\u20131288. 10.1212\/WNL.49.5.1284","journal-title":"Neurology"},{"issue":"4","key":"92_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archneur.64.4.545","volume":"64","author":"K Hara","year":"2007","unstructured":"Hara K, Momose Y, Tokiguchi S, Shimohata M, Terajima K, Onodera O, Kakita A, Yamada M, Takahashi H, Hirasawa M: Multiplex families with multiple system atrophy. Arch Neurol 2007, 64(4):545\u2013551. 10.1001\/archneur.64.4.545","journal-title":"Arch Neurol"},{"issue":"1","key":"92_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2005.09.003","volume":"240","author":"H Soma","year":"2006","unstructured":"Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H: Heredity in multiple system atrophy. J Neurol Sci 2006, 240(1):107\u2013110.","journal-title":"J Neurol Sci"},{"issue":"3","key":"92_CR10","first-page":"233","volume":"369","author":"C Multiple-System Atrophy Research","year":"2013","unstructured":"Multiple-System Atrophy Research C: Mutations in COQ2 in familial and sporadic multiple-system atrophy. New Engl J Med 2013, 369(3):233\u2013244. doi:10.1056\/NEJMoa1212115","journal-title":"New Engl J Med"},{"issue":"10","key":"92_CR11","first-page":"e1925-1914","volume":"32","author":"S Stemberger","year":"1924","unstructured":"Stemberger S, Scholz SW, Singleton AB: Wenning GK (2011) Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiol Aging 1924, 32(10):e1925\u20131914. doi:10.1016\/j.neurobiolaging.2011.04.001","journal-title":"Neurobiol Aging"},{"issue":"4","key":"92_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000078506","volume":"23","author":"V Chrysostome","year":"2004","unstructured":"Chrysostome V, Tison F, Yekhlef F, Sourgen C, Baldi I, Dartigues JF: Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology 2004, 23(4):201\u2013208. 10.1159\/000078506","journal-title":"Neuroepidemiology"},{"issue":"12","key":"92_CR13","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/mds.23185","volume":"25","author":"JH Seo","year":"2010","unstructured":"Seo JH, Yong SW, Song SK, Lee JE, Sohn YH, Lee PH: A case\u2013control study of multiple system atrophy in Korean patients. Mov Disord 2010, 25(12):1953\u20131959. 10.1002\/mds.23185","journal-title":"Mov Disord"},{"issue":"2","key":"92_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/mds.20303","volume":"20","author":"N Vanacore","year":"2005","unstructured":"Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, Stocchi F, Nicholl D, Bonuccelli U, De Mari M, Vieregge P, Meco G, Consortium E: Case\u2013control study of multiple system atrophy. Mov Disord 2005, 20(2):158\u2013163. 10.1002\/mds.20303","journal-title":"Mov Disord"},{"issue":"2","key":"92_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.expneurol.2006.01.008","volume":"199","author":"IR Vogt","year":"2006","unstructured":"Vogt IR, Lees AJ, Evert BO, Klockgether T, Bonin M, W\u00fcllner U: Transcriptional changes in multiple system atrophy and parkinson's disease putamen. Exp Neurol 2006, 199(2):465\u2013478. 10.1016\/j.expneurol.2006.01.008","journal-title":"Exp Neurol"},{"issue":"1","key":"92_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF01826052","volume":"1","author":"LE Nee","year":"1991","unstructured":"Nee LE, Gomez MR, Dambrosia J, Bale S, Eldridge R, Polinsky RJ: Environmental\u2014occupational risk factors and familial associations in multiple system atrophy: A preliminary investigation. Clin Auton Res 1991, 1(1):9\u201313. 10.1007\/BF01826052","journal-title":"Clin Auton Res"},{"issue":"1","key":"92_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp MI, Kahn JE, Lantos PL: Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989, 94(1):79\u2013100.","journal-title":"J Neurol Sci"},{"issue":"30","key":"92_CR18","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH: Lipid rafts mediate the synaptic localization of \u03b1-synuclein. J Neurosci 2004, 24(30):6715\u20136723. 10.1523\/JNEUROSCI.1594-04.2004","journal-title":"J Neurosci"},{"issue":"44","key":"92_CR19","doi-asserted-by":"crossref","first-page":"34328","DOI":"10.1074\/jbc.M004345200","volume":"275","author":"E Jo","year":"2000","unstructured":"Jo E, McLaurin JA, Yip CM, St George-Hyslop P, Fraser PE: \u03b1-Synuclein membrane interactions and lipid specificity. J Biol Chem 2000, 275(44):34328\u201334334.","journal-title":"J Biol Chem"},{"issue":"1","key":"92_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A: Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25(1):239\u2013252. 10.1016\/S0896-6273(00)80886-7","journal-title":"Neuron"},{"issue":"1","key":"92_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0014-4886(03)00004-9","volume":"181","author":"WP Gai","year":"2003","unstructured":"Gai WP, Pountney DL, Power JHT, Li QX, Culvenor JG, McLean C, Jensen PH, Blumbergs PC: \u03b1-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol 2003, 181(1):68\u201378. 10.1016\/S0014-4886(03)00004-9","journal-title":"Exp Neurol"},{"issue":"2","key":"92_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jnr.10585","volume":"72","author":"M Michikawa","year":"2003","unstructured":"Michikawa M: Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? J Neurosci Res 2003, 72(2):141\u2013146. 10.1002\/jnr.10585","journal-title":"J Neurosci Res"},{"issue":"7","key":"92_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0197-4580(03)00005-8","volume":"24","author":"C Teunissen","year":"2003","unstructured":"Teunissen C, L\u00fctjohann D, Von Bergmann K, Verhey F, Vreeling F, Wauters A, Bosmans E, Bosma H, van Boxtel M, Maes M: Combination of serum markers related to several mechanisms in Alzheimer\u2019s disease. Neurobiol Aging 2003, 24(7):893\u2013902. 10.1016\/S0197-4580(03)00005-8","journal-title":"Neurobiol Aging"},{"issue":"2","key":"92_CR24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D: Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001, 81(2):871\u2013927.","journal-title":"Physiol Rev"},{"issue":"11","key":"92_CR25","first-page":"1991","volume":"95","author":"S Ravera","year":"2013","unstructured":"Ravera S, Bartolucci M, Calzia D, Aluigi MG, Ramoino P, Morelli A, Panfoli I: Tricarboxylic acid cycle-sustained oxidative phosphorylation in isolated myelin vesicles. Biochimie 2013, 95(11):1991\u20131998. doi:10.1016\/j.biochi.2013.07.003 10.1016\/j.biochi.2013.07.003","journal-title":"Biochimie"},{"issue":"1","key":"92_CR26","first-page":"7","volume":"196","author":"JT Wang","year":"2012","unstructured":"Wang JT, Medress ZA, Barres BA: Axon degeneration: molecular mechanisms of a self-destruction pathway. J Cell Biol 2012, 196(1):7\u201318. doi:10.1083\/jcb.201108111 10.1083\/jcb.201108111","journal-title":"J Cell Biol"},{"issue":"6","key":"92_CR27","first-page":"2718","volume":"33","author":"CM Smith","year":"2013","unstructured":"Smith CM, Cooksey E, Duncan ID: Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. J Neurosci 2013, 33(6):2718\u20132727. doi:10.1523\/JNEUROSCI.4627\u201312.2013 10.1523\/JNEUROSCI.4627-12.2013","journal-title":"J Neurosci"},{"issue":"4","key":"92_CR28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","volume":"171","author":"YJ Song","year":"2007","unstructured":"Song YJ, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, Hojrup P, Otzen D, Halliday GM, Jensen PH: p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol 2007, 171(4):1291\u20131303. 10.2353\/ajpath.2007.070201","journal-title":"Am J Pathol"},{"issue":"3","key":"92_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0002-9440(10)65617-9","volume":"153","author":"A Matsuo","year":"1998","unstructured":"Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, Kimura J: Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol 1998, 153(3):735\u2013744. 10.1016\/S0002-9440(10)65617-9","journal-title":"Am J Pathol"},{"issue":"7","key":"92_CR30","first-page":"5703","volume":"280","author":"E Lindersson","year":"2005","unstructured":"Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, Jensen PH: p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem 2005, 280(7):5703\u20135715. doi:10.1074\/jbc.M410409200","journal-title":"J Biol Chem"},{"issue":"15","key":"92_CR31","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.1074\/jbc.M809671200","volume":"284","author":"CL Kragh","year":"2009","unstructured":"Kragh CL, Lund LB, Febbraro F, Hansen HD, Wei-Ping G, El-Agnaf O, Richter-Landsberg C, Jensen PH: alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. J Biol Chem 2009, 284(15):10211\u201310222. 10.1074\/jbc.M809671200","journal-title":"J Biol Chem"},{"issue":"2","key":"92_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00401-006-0167-4","volume":"113","author":"GG Kovacs","year":"2007","unstructured":"Kovacs GG, Gelpi E, Lehotzky A, Hotberger R, Erdei A, Budka H, Ovadi J: The brain-specific protein TPPP\/p25 in pathological protein deposits of neurodegenerative diseases. Acta Neuropathol 2007, 113(2):153\u2013161. 10.1007\/s00401-006-0167-4","journal-title":"Acta Neuropathol"},{"issue":"4","key":"92_CR33","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IV, Trojanowski JQ, Lee VM-Y: A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly. J Biol Chem 2001, 276(4):2380\u20132386. 10.1074\/jbc.M008919200","journal-title":"J Biol Chem"},{"issue":"10","key":"92_CR34","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1021\/bi991447r","volume":"39","author":"KA Conway","year":"2000","unstructured":"Conway KA, Harper JD, Lansbury PT Jr: Fibrils formed in vitro from \u03b1-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 2000, 39(10):2552\u20132563. 10.1021\/bi991447r","journal-title":"Biochemistry"},{"issue":"38","key":"92_CR35","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1021\/bi010616g","volume":"40","author":"J Li","year":"2001","unstructured":"Li J, Uversky VN, Fink AL: Effect of familial parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human \u03b1-synuclein. Biochemistry 2001, 40(38):11604\u201311613. 10.1021\/bi010616g","journal-title":"Biochemistry"},{"issue":"2","key":"92_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, Lansbury PT: Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci 2000, 97(2):571\u2013576. 10.1073\/pnas.97.2.571","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"92_CR37","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT Jr: \u03b1-synuclein, especially the parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 2002, 322(5):1089\u20131102. 10.1016\/S0022-2836(02)00735-0","journal-title":"J Mol Biol"},{"issue":"7","key":"92_CR38","doi-asserted-by":"publisher","first-page":"E115","DOI":"10.1038\/35017124","volume":"2","author":"MS Goldberg","year":"2000","unstructured":"Goldberg MS, Lansbury PT Jr: Is there a cause-and-effect relationship between \u03b1-synuclein fibrillization and Parkinson\u2019s disease? Nat Cell Biol 2000, 2(7):E115-E119. 10.1038\/35017124","journal-title":"Nat Cell Biol"},{"issue":"16","key":"92_CR39","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM: Stabilization of \u03b1-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 1998, 273(16):9443\u20139449. 10.1074\/jbc.273.16.9443","journal-title":"J Biol Chem"},{"issue":"45","key":"92_CR40","doi-asserted-by":"publisher","first-page":"41958","DOI":"10.1074\/jbc.M105022200","volume":"276","author":"RJ Perrin","year":"2001","unstructured":"Perrin RJ, Woods WS, Clayton DF, George JM: Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J Biol Chem 2001, 276(45):41958\u201341962. 10.1074\/jbc.M105022200","journal-title":"J Biol Chem"},{"issue":"8","key":"92_CR41","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1074\/jbc.M108414200","volume":"277","author":"NB Cole","year":"2002","unstructured":"Cole NB, Murphy DD, Grider T, Rueter S, Brasaemle D, Nussbaum RL: Lipid droplet binding and oligomerization properties of the parkinson's disease protein \u03b1-synuclein. J Biol Chem 2002, 277(8):6344\u20136352. 10.1074\/jbc.M108414200","journal-title":"J Biol Chem"},{"issue":"1","key":"92_CR42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1074\/jbc.M107045200","volume":"277","author":"HJ Lee","year":"2002","unstructured":"Lee HJ, Choi C, Lee SJ: Membrane-bound \u03b1-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 2002, 277(1):671\u2013678.","journal-title":"J Biol Chem"},{"issue":"15","key":"92_CR43","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1523\/JNEUROSCI.5725-03.2004","volume":"24","author":"L Decker","year":"2004","unstructured":"Decker L, Ffrench-Constant C: Lipid rafts and integrin activation regulate oligodendrocyte survival. J Neurosci 2004, 24(15):3816\u20133825. 10.1523\/JNEUROSCI.5725\u201303.2004 10.1523\/JNEUROSCI.5725-03.2004","journal-title":"J Neurosci"},{"issue":"7","key":"92_CR44","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1194\/jlr.E600002-JLR200","volume":"47","author":"LJ Pike","year":"2006","unstructured":"Pike LJ: Rafts defined: a report on the keystone symposium on lipid rafts and cell function. J Lipid Res 2006, 47(7):1597\u20131598. 10.1194\/jlr.E600002-JLR200","journal-title":"J Lipid Res"},{"issue":"1","key":"92_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.151.1.143","volume":"151","author":"M Simons","year":"2000","unstructured":"Simons M, Kr\u00e4mer EM, Thiele C, Stoffel W, Trotter J: Assembly of myelin by association of proteolipid protein with cholesterol-and galactosylceramide-rich membrane domains. J Cell Biol 2000, 151(1):143\u2013154. 10.1083\/jcb.151.1.143","journal-title":"J Cell Biol"},{"issue":"11","key":"92_CR46","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.1074\/jbc.270.11.6254","volume":"270","author":"K Hanada","year":"1995","unstructured":"Hanada K, Nishijima M, Akamatsu Y, Pagano RE: Both sphingolipids and cholesterol participate in the detergent insolubility of alkaline phosphatase, a glycosylphosphatidylinositol-anchored protein, in mammalian membranes. J Biol Chem 1995, 270(11):6254\u20136260. 10.1074\/jbc.270.11.6254","journal-title":"J Biol Chem"},{"issue":"18","key":"92_CR47","first-page":"5501","volume":"16","author":"P Scheiffele","year":"1997","unstructured":"Scheiffele P, Roth MG, Simons K: Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 1997, 16(18):5501\u20135508. doi:10.1093\/emboj\/16.18.5501 10.1093\/emboj\/16.18.5501","journal-title":"EMBO J"},{"issue":"41","key":"92_CR48","doi-asserted-by":"publisher","first-page":"26292","DOI":"10.1074\/jbc.273.41.26292","volume":"273","author":"PH Jensen","year":"1998","unstructured":"Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M: Binding of \u03b1-synuclein to brain vesicles is abolished by familial Parkinson\u2019s disease mutation. J Biol Chem 1998, 273(41):26292\u201326294. 10.1074\/jbc.273.41.26292","journal-title":"J Biol Chem"},{"issue":"4","key":"92_CR49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/jmbi.2001.5269","volume":"315","author":"E Jo","year":"2002","unstructured":"Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE: Defective membrane interactions of familial parkinson's disease mutant A30P \u03b1-synuclein. J Mol Biol 2002, 315(4):799\u2013807. 10.1006\/jmbi.2001.5269","journal-title":"J Mol Biol"},{"issue":"5","key":"92_CR50","first-page":"610","volume":"65","author":"SW Scholz","year":"2009","unstructured":"Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, et al.: SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009, 65(5):610\u2013614. doi:10.1002\/ana.21685 10.1002\/ana.21685","journal-title":"Ann Neurol"},{"issue":"8","key":"92_CR51","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH: Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci Offic J Soc Neurosci 1988, 8(8):2804\u20132815.","journal-title":"J Neurosci Offic J Soc Neurosci"},{"issue":"2","key":"92_CR52","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T: The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995, 14(2):467\u2013475. 10.1016\/0896-6273(95)90302-X","journal-title":"Neuron"},{"issue":"43","key":"92_CR53","doi-asserted-by":"publisher","first-page":"13709","DOI":"10.1021\/bi961799n","volume":"35","author":"PH Weinreb","year":"1996","unstructured":"Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr: NACP, a protein implicated in alzheimer's disease and learning, is natively unfolded. Biochemistry 1996, 35(43):13709\u201313715. 10.1021\/bi961799n","journal-title":"Biochemistry"},{"issue":"12","key":"92_CR54","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1074\/jbc.275.12.8812","volume":"275","author":"PJ McLean","year":"2000","unstructured":"McLean PJ, Kawamata H, Ribich S, Hyman BT: Membrane association and protein conformation of \u03b1-synuclein in intact neurons. J Biol Chem 2000, 275(12):8812\u20138816. 10.1074\/jbc.275.12.8812","journal-title":"J Biol Chem"},{"issue":"16","key":"92_CR55","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1073\/pnas.171300598","volume":"98","author":"R Sharon","year":"2001","unstructured":"Sharon R, Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ: \u03b1-synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci 2001, 98(16):9110\u20139115. 10.1073\/pnas.171300598","journal-title":"Proc Natl Acad Sci"},{"issue":"20","key":"92_CR56","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R: Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking \u03b1-synuclein. J Neurosci 2002, 22(20):8797\u20138807.","journal-title":"J Neurosci"},{"issue":"14","key":"92_CR57","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1021\/bi972776r","volume":"37","author":"JM Jenco","year":"1998","unstructured":"Jenco JM, Rawlingson A, Daniels B, Morris AJ: Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by \u03b1-and \u03b2-synucleins. Biochemistry 1998, 37(14):4901\u20134909. 10.1021\/bi972776r","journal-title":"Biochemistry"},{"issue":"4","key":"92_CR58","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jmb.2004.02.014","volume":"337","author":"JE Payton","year":"2004","unstructured":"Payton JE, Perrin RJ, Woods WS, George JM: Structural determinants of PLD2 inhibition by \u03b1-synuclein. J Mol Biol 2004, 337(4):1001\u20131009. 10.1016\/j.jmb.2004.02.014","journal-title":"J Mol Biol"},{"issue":"Pt 3","key":"92_CR59","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/bj3450401","volume":"345","author":"M Liscovitch","year":"2000","unstructured":"Liscovitch M, Czarny M, Fiucci G, Tang X: Phospholipase D: molecular and cell biology of a novel gene family. Biochem J 2000, 345(Pt 3):401.","journal-title":"Biochem J"},{"issue":"2","key":"92_CR60","first-page":"462","volume":"44","author":"V Narayanan","year":"2005","unstructured":"Narayanan V, Guo Y, Scarlata S: Fluorescence studies suggest a role for alpha-synuclein in the phosphatidylinositol lipid signaling pathway. Biochemistry 2005, 44(2):462\u2013470. doi:10.1021\/bi0487140 10.1021\/bi0487140","journal-title":"Biochemistry"},{"issue":"5","key":"92_CR61","first-page":"1109","volume":"24","author":"Y Guo","year":"2012","unstructured":"Guo Y, Rosati B, Scarlata S: alpha-Synuclein increases the cellular level of phospholipase Cbeta1. Cell Signal 2012, 24(5):1109\u20131114. doi:10.1016\/j.cellsig.2012.01.007 10.1016\/j.cellsig.2012.01.007","journal-title":"Cell Signal"},{"issue":"3","key":"92_CR62","first-page":"839","volume":"94","author":"PI Castagnet","year":"2005","unstructured":"Castagnet PI, Golovko MY, Barcelo-Coblijn GC, Nussbaum RL, Murphy EJ: Fatty acid incorporation is decreased in astrocytes cultured from alpha-synuclein gene-ablated mice. J Neurochem 2005, 94(3):839\u2013849. doi:10.1111\/j.1471\u20134159.2005.03247.x 10.1111\/j.1471-4159.2005.03247.x","journal-title":"J Neurochem"},{"issue":"23","key":"92_CR63","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1021\/bi0502137","volume":"44","author":"MY Golovko","year":"2005","unstructured":"Golovko MY, Faergeman NJ, Cole NB, Castagnet PI, Nussbaum RL, Murphy EJ: \u03b1-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of \u03b1-synuclein palmitate binding. Biochemistry 2005, 44(23):8251\u20138259. 10.1021\/bi0502137","journal-title":"Biochemistry"},{"issue":"22","key":"92_CR64","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1021\/bi0600289","volume":"45","author":"MY Golovko","year":"2006","unstructured":"Golovko MY, Rosenberger TA, F\u00e6rgeman NJ, Feddersen S, Cole NB, Pribill I, Berger J, Nussbaum RL, Murphy EJ: Acyl-CoA synthetase activity links wild-type but not mutant \u03b1-synuclein to brain arachidonate metabolism. Biochemistry 2006, 45(22):6956\u20136966. 10.1021\/bi0600289","journal-title":"Biochemistry"},{"issue":"22","key":"92_CR65","doi-asserted-by":"publisher","first-page":"10190","DOI":"10.1128\/MCB.25.22.10190-10201.2005","volume":"25","author":"CE Ellis","year":"2005","unstructured":"Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcel\u00f3-Coblijn GC, Nussbaum RL: Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking \u03b1-synuclein. Mol Cell Biol 2005, 25(22):10190\u201310201. 10.1128\/MCB.25.22.10190-10201.2005","journal-title":"Mol Cell Biol"},{"issue":"3","key":"92_CR66","first-page":"418","volume":"12","author":"M Gu","year":"1997","unstructured":"Gu M, Gash MT, Cooper JM, Wenning GK, Daniel SE, Quinn NP, Marsden CD, Schapira AH: Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 1997, 12(3):418\u2013422. doi:10.1002\/mds.870120323 10.1002\/mds.870120323","journal-title":"Mov Disord"},{"issue":"3","key":"92_CR67","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","volume":"166","author":"N Stefanova","year":"2005","unstructured":"Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK: Oxidative stress in transgenic mice with oligodendroglial \u03b1-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 2005, 166(3):869\u2013876. 10.1016\/S0002-9440(10)62307-3","journal-title":"Am J Pathol"},{"issue":"12","key":"92_CR68","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/jnr.22089","volume":"87","author":"K Ubhi","year":"2009","unstructured":"Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E, Stefanova N, Wenning GK, Masliah E: Mitochondrial inhibitor 3\u2012nitroproprionic acid enhances oxidative modification of alpha\u2012synuclein in a transgenic mouse model of multiple system atrophy. J Neurosci Res 2009, 87(12):2728\u20132739. 10.1002\/jnr.22089","journal-title":"J Neurosci Res"},{"issue":"9","key":"92_CR69","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/jnen\/59.9.830","volume":"59","author":"JE Duda","year":"2000","unstructured":"Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M: Immunohistochemical and biochemical studies demonstrate a distinct profile of [alpha]-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol 2000, 59(9):830.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"92_CR70","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","volume":"155","author":"D Dickson","year":"1999","unstructured":"Dickson D, Liu WK, Hardy J, Farrer M, Mehta N, Uitti R, Mark M, Zimmerman T, Golbe L, Sage J: Widespread alterations of \u03b1-synuclein in multiple system atrophy. Am J Pathol 1999, 155(4):1241\u20131251. 10.1016\/S0002-9440(10)65226-1","journal-title":"Am J Pathol"},{"issue":"48","key":"92_CR71","doi-asserted-by":"publisher","first-page":"48120","DOI":"10.1074\/jbc.M306889200","volume":"278","author":"AC Pawlyk","year":"2003","unstructured":"Pawlyk AC, Giasson BI, Sampathu DM, Perez FA, Lim KL, Dawson VL, Dawson TM, Palmiter RD, Trojanowski JQ, Lee VMY: Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age. J Biol Chem 2003, 278(48):48120\u201348128. 10.1074\/jbc.M306889200","journal-title":"J Biol Chem"},{"issue":"1","key":"92_CR72","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/brain\/awp282","volume":"133","author":"J Tong","year":"2010","unstructured":"Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O: Brain \u03b1-synuclein accumulation in multiple system atrophy, parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain 2010, 133(1):172\u2013188. 10.1093\/brain\/awp282","journal-title":"Brain"},{"issue":"3","key":"92_CR73","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2353\/ajpath.2006.050770","volume":"168","author":"K Uryu","year":"2006","unstructured":"Uryu K, Richter-Landsberg C, Welch W, Sun E, Goldbaum O, Norris EH, Pham CT, Yazawa I, Hilburger K, Micsenyi M: Convergence of heat shock protein 90 with ubiquitin in filamentous \u03b1-synuclein inclusions of \u03b1-synucleinopathies. Am J Pathol 2006, 168(3):947\u2013961. 10.2353\/ajpath.2006.050770","journal-title":"Am J Pathol"},{"issue":"3","key":"92_CR74","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.410440324","volume":"44","author":"P Tu","year":"1998","unstructured":"Tu P, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VMY: Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble \u03b1\u2012synuclein. Ann Neurol 1998, 44(3):415\u2013422. 10.1002\/ana.410440324","journal-title":"Ann Neurol"},{"issue":"2","key":"92_CR75","first-page":"345","volume":"78","author":"C Quinzii","year":"2006","unstructured":"Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, Dimauro S, Hirano M: A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 2006, 78(2):345\u2013349. doi:10.1086\/500092 10.1086\/500092","journal-title":"Am J Hum Genet"},{"issue":"1\u20132","key":"92_CR76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbamem.2003.11.012","volume":"1660","author":"M Turunen","year":"2004","unstructured":"Turunen M, Olsson J, Dallner G: Metabolism and function of coenzyme Q. Biochim Biophys Acta 2004, 1660(1\u20132):171\u2013199.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"92_CR77","first-page":"1874","volume":"22","author":"CM Quinzii","year":"2008","unstructured":"Quinzii CM, Lopez LC, Von-Moltke J, Naini A, Krishna S, Schuelke M, Salviati L, Navas P, DiMauro S, Hirano M: Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J Offic Publ Fed Am Soc Exp Biol 2008, 22(6):1874\u20131885. doi:10.1096\/fj.07\u2013100149","journal-title":"FASEB J Offic Publ Fed Am Soc Exp Biol"},{"issue":"10","key":"92_CR78","first-page":"3733","volume":"24","author":"CM Quinzii","year":"2010","unstructured":"Quinzii CM, Lopez LC, Gilkerson RW, Dorado B, Coku J, Naini AB, Lagier-Tourenne C, Schuelke M, Salviati L, Carrozzo R, Santorelli F, Rahman S, Tazir M, Koenig M, DiMauro S, Hirano M: Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J Offic Publ Fed Am Soc Exp Biol 2010, 24(10):3733\u20133743. doi:10.1096\/fj.09\u2013152728","journal-title":"FASEB J Offic Publ Fed Am Soc Exp Biol"},{"issue":"7","key":"92_CR79","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1212\/01.WNL.0000055089.39373.FC","volume":"60","author":"C Lamperti","year":"2003","unstructured":"Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S, Valeriani M, Lynch D, Banwell B, Berg M, Dubrovsky T, Chiriboga C, Angelini C, Pegoraro E, DiMauro S: Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 2003, 60(7):1206\u20131208. 10.1212\/01.WNL.0000055089.39373.FC","journal-title":"Neurology"},{"issue":"1\u20132","key":"92_CR80","first-page":"153","volume":"246","author":"R Artuch","year":"2006","unstructured":"Artuch R, Brea-Calvo G, Briones P, Aracil A, Galvan M, Espinos C, Corral J, Volpini V, Ribes A, Andreu AL, Palau F, Sanchez-Alcazar JA, Navas P, Pineda M: Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation. J Neurol Sci 2006, 246(1\u20132):153\u2013158. doi:10.1016\/j.jns.2006.01.021","journal-title":"J Neurol Sci"},{"issue":"7399","key":"92_CR81","first-page":"517","volume":"485","author":"U Funfschilling","year":"2012","unstructured":"Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Mobius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA: Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012, 485(7399):517\u2013521. doi:10.1038\/nature11007","journal-title":"Nature"},{"issue":"6712","key":"92_CR82","first-page":"703","volume":"396","author":"LW Hung","year":"1998","unstructured":"Hung LW, Wang IX, Nikaido K, Liu PQ, Ames GF, Kim SH: Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 1998, 396(6712):703\u2013707. doi:10.1038\/25393 10.1038\/25393","journal-title":"Nature"},{"issue":"2","key":"92_CR83","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0005-2736(99)00161-3","volume":"1461","author":"I Klein","year":"1999","unstructured":"Klein I, Sarkadi B, Varadi A: An inventory of the human ABC proteins. Biochim Biophys Acta 1999, 1461(2):237\u2013262. 10.1016\/S0005-2736(99)00161-3","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"92_CR84","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.bbadis.2006.01.011","volume":"1762","author":"WE Kaminski","year":"2006","unstructured":"Kaminski WE, Piehler A, Wenzel JJ: ABC A-subfamily transporters: structure, function and disease. Bioch Biophy Acta (BBA)-Mol Basis Dis 2006, 1762(5):510\u2013524. 10.1016\/j.bbadis.2006.01.011","journal-title":"Bioch Biophy Acta (BBA)-Mol Basis Dis"},{"issue":"5","key":"92_CR85","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1471-4159.2007.05099.x","volume":"104","author":"WS Kim","year":"2008","unstructured":"Kim WS, Weickert CS, Garner B: Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem 2008, 104(5):1145\u20131166. 10.1111\/j.1471-4159.2007.05099.x","journal-title":"J Neurochem"},{"issue":"3","key":"92_CR86","first-page":"401","volume":"452","author":"WS Kim","year":"2013","unstructured":"Kim WS, Hsiao JH, Bhatia S, Glaros EN, Don AS, Tsuruoka S, Shannon Weickert C, Halliday GM: ABCA8 stimulates sphingomyelin production in oligodendrocytes. Biochem J 2013, 452(3):401\u2013410. doi:10.1042\/BJ20121764 10.1042\/BJ20121764","journal-title":"Biochem J"},{"issue":"6","key":"92_CR87","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/archpsyc.1994.03950060041004","volume":"51","author":"FM Benes","year":"1994","unstructured":"Benes FM, Turtle M, Khan Y, Farol P: Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 1994, 51(6):477\u2013484. 10.1001\/archpsyc.1994.03950060041004","journal-title":"Arch Gen Psychiatry"},{"issue":"41","key":"92_CR88","doi-asserted-by":"publisher","first-page":"16480","DOI":"10.1073\/pnas.1117943109","volume":"109","author":"DJ Miller","year":"2012","unstructured":"Miller DJ, Duka T, Stimpson CD, Schapiro SJ, Baze WB, McArthur MJ, Fobbs AJ, Sousa AMM, \u0160estan N, Wildman DE: Prolonged myelination in human neocortical evolution. Proc Natl Acad Sci U S A 2012, 109(41):16480\u201316485. 10.1073\/pnas.1117943109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"92_CR89","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0005-2736(80)90572-6","volume":"604","author":"Y Barenholz","year":"1980","unstructured":"Barenholz Y, Thompson T: Sphingomyelins in bilayers and biological membranes. Biochimica et biophysica acta (BBA)-reviews on. Biomembranes 1980, 604: 129\u2013158. 10.1016\/0005-2736(80)90572-6","journal-title":"Biomembranes"},{"issue":"44","key":"92_CR90","doi-asserted-by":"publisher","first-page":"36815","DOI":"10.1074\/jbc.M504484200","volume":"280","author":"L Kalvodova","year":"2005","unstructured":"Kalvodova L, Kahya N, Schwille P, Ehehalt R, Verkade P, Drechsel D, Simons K: Lipids as modulators of proteolytic activity of BACE involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J Biol Chem 2005, 280(44):36815\u201336823. 10.1074\/jbc.M504484200","journal-title":"J Biol Chem"},{"key":"92_CR91","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3350465","volume":"335","author":"S Mathias","year":"1998","unstructured":"Mathias S, Pena L, Kolesnick R: Signal transduction of stress via ceramide. Biochem J 1998, 335: 465\u2013480.","journal-title":"Biochem J"},{"issue":"2","key":"92_CR92","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1073\/pnas.55.2.366","volume":"55","author":"RO Brady","year":"1966","unstructured":"Brady RO, Kanfer JN, Mock MB, Fredrickson DS: The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci U S A 1966, 55(2):366\u2013369. 10.1073\/pnas.55.2.366","journal-title":"Proc Natl Acad Sci U S A"},{"key":"92_CR93","volume-title":"J Parkinson\u2019s Dis","author":"JM Bleasel","year":"2013","unstructured":"Bleasel JM, Hsiao JT, Halliday GM, Kim WS: Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. J Parkinson\u2019s Dis 2013. published online 24 June 2013"},{"issue":"1","key":"92_CR94","first-page":"145","volume":"55","author":"H Jin","year":"2008","unstructured":"Jin H, Ishikawa K, Tsunemi T, Ishiguro T, Amino T, Mizusawa H: Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy. J Med Dent Sci 2008, 55(1):145\u2013153.","journal-title":"J Med Dent Sci"},{"issue":"6","key":"92_CR95","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/mds.21259","volume":"22","author":"AJ Langerveld","year":"2007","unstructured":"Langerveld AJ, Mihalko D, DeLong C, Walburn J, Ide CF: Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients. Mov Disord 2007, 22(6):766\u2013777. 10.1002\/mds.21259","journal-title":"Mov Disord"},{"issue":"12","key":"92_CR96","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","volume":"112","author":"D Miller","year":"2005","unstructured":"Miller D, Johnson J, Solano S, Hollingsworth Z, Standaert D, Young A: Absence of \u03b1-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 2005, 112(12):1613\u20131624. 10.1007\/s00702-005-0378-1","journal-title":"J Neural Transm"},{"issue":"3","key":"92_CR97","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-007-0254-1","volume":"114","author":"T Ozawa","year":"2007","unstructured":"Ozawa T: Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum. Acta Neuropathol 2007, 114(3):201\u2013211. 10.1007\/s00401-007-0254-1","journal-title":"Acta Neuropathol"},{"issue":"5","key":"92_CR98","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/mds.22459","volume":"24","author":"PH Lee","year":"2009","unstructured":"Lee PH, Lim TS, Shin HW, Yong SW, Nam HS, Sohn YH: Serum cholesterol levels and the risk of multiple system atrophy: a case-control study. Movement Disorders 2009, 24(5):752\u2013758. 10.1002\/mds.22459","journal-title":"Movement Disorders"},{"key":"92_CR99","unstructured":"Cao B, Guo X, Chen K, Song W, Huang R, Wei QQ, Zhao B, Shang HF: Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population. Neurol Res 10.1179\/1743132813Y.0000000277"},{"issue":"6","key":"92_CR100","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/mds.21857","volume":"23","author":"JS Vidal","year":"2008","unstructured":"Vidal JS, Vidailhet M, Elbaz A, Derkinderen P, Tzourio C, Alperovitch A: Risk factors of multiple system atrophy: a case\u2013control study in French patients. Mov Disord 2008, 23(6):797\u2013803. 10.1002\/mds.21857","journal-title":"Mov Disord"},{"issue":"10","key":"92_CR101","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/aje\/kwj283","volume":"164","author":"LML de Lau","year":"2006","unstructured":"de Lau LML, Koudstaal PJ, Hofman A, Breteler MMB: Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol 2006, 164(10):998\u20131002. 10.1093\/aje\/kwj283","journal-title":"Am J Epidemiol"},{"issue":"17","key":"92_CR102","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1212\/01.wnl.0000271883.45010.8a","volume":"69","author":"KC Simon","year":"2007","unstructured":"Simon KC, Chen H, Schwarzschild M, Ascherio A: Hypertension, hypercholesterolemia, diabetes, and risk of parkinson disease. Neurology 2007, 69(17):1688\u20131695. 10.1212\/01.wnl.0000271883.45010.8a","journal-title":"Neurology"},{"issue":"5","key":"92_CR103","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/01.STR.0000217384.03237.9c","volume":"37","author":"G Scigliano","year":"2006","unstructured":"Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G, Girotti F: Reduced risk factors for vascular disorders in parkinson disease patients a case\u2013control study. Stroke 2006, 37(5):1184\u20131188. 10.1161\/01.STR.0000217384.03237.9c","journal-title":"Stroke"},{"issue":"3","key":"92_CR104","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/mds.21290","volume":"22","author":"X Huang","year":"2007","unstructured":"Huang X, Chen H, Miller WC, Mailman RB, Woodard JL, Chen PC, Xiang D, Murrow RW, Wang YZ, Poole C: Lower low\u2012density lipoprotein cholesterol levels are associated with parkinson's disease. Mov Disord 2007, 22(3):377\u2013381. 10.1002\/mds.21290","journal-title":"Mov Disord"},{"issue":"21","key":"92_CR105","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1212\/01.wnl.0000312511.62699.a8","volume":"70","author":"G Hu","year":"2008","unstructured":"Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J: Total cholesterol and the risk of parkinson disease. Neurology 2008, 70(21):1972\u20131979. 10.1212\/01.wnl.0000312511.62699.a8","journal-title":"Neurology"},{"issue":"12","key":"92_CR106","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/oxfordjournals.aje.a116960","volume":"139","author":"A Grandinetti","year":"1994","unstructured":"Grandinetti A, Morens DM, Reed D, MacEachern D: Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994, 139(12):1129\u20131138.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"92_CR107","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/ije\/28.6.1102","volume":"28","author":"C Johnson","year":"1999","unstructured":"Johnson C, Gorell J, Rybicki B, Sanders K, Peterson E: Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 1999, 28(6):1102\u20131109. 10.1093\/ije\/28.6.1102","journal-title":"Int J Epidemiol"},{"issue":"1","key":"92_CR108","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ana.410390113","volume":"39","author":"G Logroscino","year":"1996","unstructured":"Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R: Dietary lipids and antioxidants in Parkinson's disease: a population\u2012based, case\u2012control study. Ann Neurol 1996, 39(1):89\u201394. 10.1002\/ana.410390113","journal-title":"Ann Neurol"},{"issue":"1","key":"92_CR109","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/1531-8257(199901)14:1<21::AID-MDS1006>3.0.CO;2-Y","volume":"14","author":"C Anderson","year":"1999","unstructured":"Anderson C, Checkoway H, Franklin GM, Beresford S, Smith\u2012Weller T, Swanson PD: Dietary factors in parkinson's disease: the role of food groups and specific foods. Mov Disord 1999, 14(1):21\u201327. 10.1002\/1531-8257(199901)14:1<21::AID-MDS1006>3.0.CO;2-Y","journal-title":"Mov Disord"},{"issue":"12","key":"92_CR110","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","volume":"64","author":"L de Lau","year":"2005","unstructured":"de Lau L, Bornebroek M, Witteman J, Hofman A, Koudstaal P, Breteler M: Dietary fatty acids and the risk of parkinson disease the Rotterdam Study. Neurology 2005, 64(12):2040\u20132045. 10.1212\/01.WNL.0000166038.67153.9F","journal-title":"Neurology"},{"issue":"1","key":"92_CR111","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2008.03.002","volume":"15","author":"KM Powers","year":"2009","unstructured":"Powers KM, Smith-Weller T, Franklin GM, Longstreth W Jr, Swanson PD, Checkoway H: Dietary fats, cholesterol and iron as risk factors for parkinson's disease. Parkinsonism Relat Disord 2009, 15(1):47\u201352. 10.1016\/j.parkreldis.2008.03.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"92_CR112","first-page":"iii30","volume":"250","author":"GW Ross","year":"2003","unstructured":"Ross GW, White LR, Sanderson WT, Burchfiel CM, Kashon M, Sharp DS, Masaki KH, Curb JD, Petrovitch H: Environmental, life-style, and physical precursors of clinical parkinson\u2019s disease: recent findings from the Honolulu-Asia aging study. J Neurol 2003, 250(3):iii30-iii39.","journal-title":"J Neurol"},{"issue":"11","key":"92_CR113","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/aje\/kwg073","volume":"157","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hern\u00e1n MA, Willett WC, Ascherio A: Dietary intakes of fat and risk of parkinson\u2019s disease. Am J Epidemiol 2003, 157(11):1007\u20131014.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"92_CR114","first-page":"363","volume":"3","author":"K Gudala","year":"2013","unstructured":"Gudala K, Bansal D, Muthyala H: Role of serum cholesterol in Parkinson's disease: a meta-analysis of evidence. J Parkinson's Dis 2013, 3(3):363\u2013370. doi:10.3233\/JPD-130196","journal-title":"J Parkinson's Dis"},{"issue":"5","key":"92_CR115","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","volume":"24","author":"I Bj\u00f6rkhem","year":"2004","unstructured":"Bj\u00f6rkhem I, Meaney S: Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004, 24(5):806\u2013815. 10.1161\/01.ATV.0000120374.59826.1b","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"92_CR116","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bj\u00f6rkhem","year":"1998","unstructured":"Bj\u00f6rkhem I, L\u00fctjohann D, Diczfalusy U, St\u00e5hle L, Ahlborg G, Wahren J: Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 1998, 39(8):1594\u20131600.","journal-title":"J Lipid Res"},{"issue":"5","key":"92_CR117","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1194\/jlr.M500024-JLR200","volume":"46","author":"M Heverin","year":"2005","unstructured":"Heverin M, Meaney S, L\u00fctjohann D, Diczfalusy U, Wahren J, Bj\u00f6rkhem I: Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res 2005, 46(5):1047\u20131052. 10.1194\/jlr.M500024-JLR200","journal-title":"J Lipid Res"},{"issue":"5","key":"92_CR118","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nchembio782","volume":"2","author":"DA Bosco","year":"2006","unstructured":"Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth P, Lerner RA, Kelly JW: Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate \u03b1-synuclein fibrilization. Nat Chem Biol 2006, 2(5):249\u2013253. 10.1038\/nchembio782","journal-title":"Nat Chem Biol"},{"issue":"15","key":"92_CR119","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","volume":"95","author":"RT Matthews","year":"1998","unstructured":"Matthews RT, Yang L, Browne S, Baik M, Beal MF: Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci 1998, 95(15):8892\u20138897. 10.1073\/pnas.95.15.8892","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"92_CR120","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","volume":"59","author":"CW Shults","year":"2002","unstructured":"Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J: Effects of coenzyme Q10 in early parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002, 59(10):1541. 10.1001\/archneur.59.10.1541","journal-title":"Arch Neurol"},{"issue":"2","key":"92_CR121","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0014-5793(98)01712-8","volume":"443","author":"J Kaikkonen","year":"1999","unstructured":"Kaikkonen J, Nyyssonen K, Tuomainen TP, Ristonmaa U, Salonen JT: Determinants of plasma coenzyme Q10 in humans. FEBS Lett 1999, 443(2):163\u2013166. 10.1016\/S0014-5793(98)01712-8","journal-title":"FEBS Lett"},{"issue":"1\u20134","key":"92_CR122","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/biof.5520180217","volume":"18","author":"A Naini","year":"2003","unstructured":"Naini A, Lewis VJ, Hirano M, DiMauro S: Primary coenzyme Q10 deficiency and the brain. Biofactors 2003, 18(1\u20134):145\u2013152.","journal-title":"Biofactors"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2051-5960-2-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:00:07Z","timestamp":1630537207000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-2-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,7]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["92"],"URL":"https:\/\/doi.org\/10.1186\/2051-5960-2-15","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,7]]},"assertion":[{"value":"3 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}